Curatis Holding Ltd header image

Curatis Holding Ltd

CURN

Equity

ISIN CH1330780979 / Valor 133078097

SIX Swiss Exchange (2026-05-29)
CHF 24.90+2.05%

Curatis Holding Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Curatis Holding Ltd is a Swiss-based pharmaceutical company specializing in the acquisition, licensing, distribution, and promotion of medicines for the treatment and prevention of orphan and specialty diseases. The company holds exclusive distribution rights for over 30 different drugs within Switzerland, many of which target rare and specialized medical conditions. Curatis is actively working to expand its market presence by securing distribution rights in major European markets, including Germany, France, the UK, and Italy. In the medium to long term, the company plans to launch its own products pending regulatory approval. Curatis' growth strategy is bolstered by its aim to increase visibility and funding opportunities through potential public listing. The executive management team, including CFO Patrick Ramsauer, brings extensive experience in finance and corporate governance, further supporting the company's strategic objectives.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

91.5%1Y
%3Y
%5Y

Performance

78.8%1Y
101%3Y
101%5Y

Volatility

Market cap

79 M

Market cap (USD)

Daily traded volume (Shares)

2,655

Daily traded volume (Shares)

1 day high/low

13.5 / 13

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.28%USD 3.95
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.75%USD 10.47
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG Carl Zeiss Meditec AG Valor: 1055489
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.19%EUR 25.88
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.12%CHF 76.85
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%GBP 14.76
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%CHF 83.35
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.69%CHF 4.47
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.39%CHF 350.40
Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.97%GBP 26.72
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.43%CHF 143.20